Is an extended dose of subcutaneous nadroparin anticoagulation equally safe and feasible compared to unfractionated heparin anticoagulation during extracorporeal membrane oxygenation in critically ill COVID-19 patients?
UFH anticoagulation may provide better flow optimization in the oxygenator, but the risk of life-threatening bleeding may increase. The present findings need to be fully elucidated in prospective studies on a larger critically ill population supported with respiratory ECMO.
Authors
- Michał Borys (ORCID: https://orcid.org/0000-0002-6183-811X)
- Mirosław Czuczwar (ORCID: https://orcid.org/0000-0002-9025-6717)
- Marta Szczukocka (ORCID: https://orcid.org/0000-0003-1431-5495)
- Paweł Kutnik (ORCID: https://orcid.org/0000-0002-8434-6812)
- Tomasz Czarnik (ORCID: https://orcid.org/0000-0002-6734-978X)
- Paweł Piwowarczyk (ORCID: https://orcid.org/0000-0002-8529-484X)
- Agata Uchacz
Institutions
- John Paul II Catholic University of Lublin (PL)
- Opole University of Technology (PL)
- University of Opole (PL)
Publication Details
- Journal
- Anaesthesiology Intensive Therapy
- Published
- 2025-04-15
- DOI
- https://doi.org/10.5114/ait/202605
- Citations
- 1
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.67